Villa E, Grottola A, Buttafoco P, Trande P, Merighi A, Fratti N, Seium Y, Cioni G, Manenti F
Chair of Gastroenterology, University of Modena, Italy.
Dig Dis Sci. 1995 Jan;40(1):8-13. doi: 10.1007/BF02063934.
To assess the influence of HBV infection on anti-HCV-positive chronic liver disease, we performed a prospective case-control study comparing 19 HBsAg-positive, anti-HCV-positive patients with 38 HBsAg-negative, anti-HCV-positive patients, pair-matched for age, sex, and ALT levels. HBV and HCV infections were investigated by standard serology and polymerase chain reaction. HCV RNA was found in all patients with CAH and in 90.0% with cirrhosis (33% HBsAg-positive). HBV DNA sequences were found, in the HBsAg-positive subjects, in 71.4% of CAH and in 83.3% of cirrhotics; in the HBsAg-negative ones, only 10% of CAH but 77.7% of cirrhotics had demonstrable HBV DNA sequences. Consequently, 80.0% of cirrhotics had evidence of both HBV and HCV infection. Conventional serology gives partial information on the true occurrence of HBV infection in HBsAg-negative patients, while PCR defines more accurately the HBV status. When the rate of double infection is defined in this way, it correlates with the presence of cirrhosis.
为评估HBV感染对抗-HCV阳性慢性肝病的影响,我们进行了一项前瞻性病例对照研究,比较了19例HBsAg阳性、抗-HCV阳性患者与38例HBsAg阴性、抗-HCV阳性患者,根据年龄、性别和ALT水平进行配对。通过标准血清学和聚合酶链反应对HBV和HCV感染进行调查。所有慢性活动性肝炎(CAH)患者及90.0%的肝硬化患者检测到HCV RNA(33%为HBsAg阳性)。在HBsAg阳性受试者中,71.4%的CAH患者及83.3%的肝硬化患者检测到HBV DNA序列;在HBsAg阴性受试者中,仅10%的CAH患者及77.7%的肝硬化患者检测到可证实的HBV DNA序列。因此,80.0%的肝硬化患者有HBV和HCV双重感染的证据。传统血清学只能提供关于HBsAg阴性患者中HBV感染实际发生率的部分信息,而PCR能更准确地确定HBV状态。当以这种方式定义双重感染率时,其与肝硬化的存在相关。